SLC22A2 antibody

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline(norepinephrine), serotonin, choline, famotidine, ranitidine, histamin, creatinine, amantadine, memantine, acriflavine, 4-[4-(dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide(NMN), tetraethylammonium(TEA), 1-methyl-4-phenylpyridinium(MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as DX-619 and LVFX. This transporter is a major determinant of the anticancer activity of oxaliplatin and may contribute to antitumor specificity.
Documents del producto
Product specifications
Category | Primary Antibodies |
Immunogen Target | solute carrier family 22(organic cation transporter), member 2 (SLC22A2) |
Host | Rabbit |
Reactivity | Human, Mouse, Rat |
Recommended Dilution | WB: 1:500-1:2000 |
Clonality | polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Observed MW | 60-70 kDa |
Purity | ≥95% as determined by SDS-PAGE |
Purification | Immunogen affinity purified |
Size 1 | 100µg |
Form | liquid |
Tested Applications | ELISA, WB |
Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
UniProt ID | O15244 |
Gene ID | 6582 |
Alias | Solute carrier family 22 member 2,Organic cation transporter 2 (hOCT2),SLC22A2,45567 |
Background | Antibody anti-SLC22A2 |
Status | RUO |
Note | Mol. Weight 60-70 kDa |
Descripción
Related Products

SLC22A2 antibody
Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline(norepinephrine), serotonin, choline, famotidine, ranitidine, histamin, creatinine, amantadine, memantine, acriflavine, 4-[4-(dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide(NMN), tetraethylammonium(TEA), 1-methyl-4-phenylpyridinium(MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as DX-619 and LVFX. This transporter is a major determinant of the anticancer activity of oxaliplatin and may contribute to antitumor specificity.
Ver Producto
Solute Carrier Family 22 Member 2 (SLC22A2) Antibody
SLC22A2 Antibody is a Rabbit Polyclonal Antibody against SLC22A2.
Ver Producto
Solute Carrier Family 22 Member 2 (SLC22A2) Antibody
Solute Carrier Family 22 (Organic Cation Transporter), Member 2 Antibody is a Rabbit Polyclonal antibody against Solute Carrier Family 22 (Organic Cation Transporter), Member 2.
Ver Producto